Pfizer Director, HEOR Vaccines Pipeline in New York City, New York

The Director, Health Economics & Outcomes Research (HEOR) Vaccines Pipeline is responsible for development and execution of high quality HEOR strategic efforts to support optimal reimbursement and access for multiple early vaccine assets, and pre-clinical and business development opportunities, with a focus on delivering robust evidence demonstrating the value of the product(s), successfully impacting business objectives on a global basis.

The HEOR Director will function with a one-Patient and Health Impact (PHI) mindset and work in a closely aligned fashion with the full team to ensure there is a single and coordinated view on strategy and delivery from PHI to the business. The HEOR Director will be a strategic partner to the assigned disease area or asset teams and will work to implement an HEOR strategy that supports the asset(s).

About Pfizer Patient and Health Impact

Patient and Health Impact (PHI) is a group within Pfizer that brings together experts in health economics and outcomes research, real-world data, patient-centered outcomes assessment, market access, pricing, strategy and contracting. This group is responsible for ensuring patients have affordable, timely access to medicines and vaccines that can help optimize their overall health by generating evidence of value and working with payers and governments around the world to create access. Recognizing challenges with healthcare sustainability and the evolution to value-based care, this group is also exploring innovative approaches and new partnerships to transform the way Pfizer brings medicines and vaccines to market. We recognize our responsibility to be part of the solution and aim to be a leader in the industry.

PHI offers colleagues a distinct opportunity to support evidence-generation and market access strategies across Pfizer's entire portfolio through all lifecycle stages - from early pipeline to marketed brands to loss of exclusivity and switch to over the counter. Colleagues in PHI have an unparalleled opportunity to grow and develop, while making a meaningful contribution to patient and population health around the world.


  • Partner with the global product / therapeutic area asset teams to execute the Global HEOR strategy to support the value of early pipeline vaccine assets in the Vaccine Business Unit.

  • Develop the strategy for and lead the execution of HEOR studies and projects in alignment with the global HEOR strategy to support and enhance the value proposition for the assets. May include some or all of the following:

  • Create and maintain value stories, evidence blueprints, payer value messages and innovative tools

  • Develop and utilize early cost-effectiveness and health impact model(s) to communicate the public health and economic value of the asset(s)

  • Develop real world evidence generation strategies and execute studies (e.g. treatment patterns, real world effectiveness, burden of illness, costing, epidemiology studies, etc.) within non-interventional study processes

  • Incorporate humanistic and economic endpoints into clinical trials registries, and prospective real world studies across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy & access targets for the asset(s)

  • Lead the collaboration and communication with external experts on evidence generation and scientific data exchange

  • Provide expertise and insights to support internal efforts on evaluation of new business opportunities

  • Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy

  • Lead the coordination of input from country Health & Value teams on evidence needs and ensure that the input is appropriately incorporated into the global market access and data generation strategy

  • Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers

  • Assess, synthesize, and interpret relevant literature and communicate findings to internal and external stakeholders

  • Execute and manage research projects with external collaborators/vendors to ensure timely completion and quality of deliverables as well as budget/legal compliance

  • Influence HEOR policies and methodological advances inside and outside the company by leading key cross-divisional task forces to help improve processes and standards in HEOR research programs.


  • Graduate degree in health services research, public health, epidemiology, or health economics

  • 10+ years of experience in HEOR and relevant related fields desirable

  • Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to:

  • Health economics

  • Cost-effectiveness / budgetary impact modeling

  • Prospective and retrospective data analyses

  • Patient reported outcomes measures

  • Real world evidence studies

  • Epidemiology

  • Statistics

  • Knowledge and experience in Vaccine therapeutic areas is strongly preferred

  • Able to independently engage all levels of stakeholders through a strong customer orientation, strategic thinking, leading change, and building collaborative partnerships in a matrix environment

  • Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly

  • Experience with HTA organizations such as ACIP, JCVI, and other vaccine technical committees desirable

  • Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities in a compliant manner

  • Excellent oral and written English communication skills are required

Location: R emote based with a preference for NYC or Collegeville is preferred

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

  • Last Date to Apply for Job: 5/21/2018

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.